The Diagnostic Journey: MRI and Genetics

The journey to a BTBGD diagnosis is often a race against time. Because the symptoms—like sudden confusion or loss of balance—can look like many other brain conditions, the diagnosis is frequently delayed ^[1]. Understanding the specific patterns doctors look for in brain scans and genetic tests can help you ensure your child receives the correct life-changing treatment as quickly as possible.

Finding Clues on the MRI

The name of the disease itself points to the primary imaging area: the basal ganglia, a group of structures deep in the brain that control movement. In BTBGD, an MRI will typically show “lesions” or bright spots (technically called T2/FLAIR hyperintensities) in these areas ^[2].

• The Putamen: This is a very common area affected. In many childhood cases, both the left and right putamen show clear signs of distress ^[3].
• The Caudate: While often affected in older children, doctors have found that the caudate (another part of the basal ganglia) can appear perfectly normal in the early stages of the disease. An MRI that does not show caudate lesions—or is completely normal early on—does not rule out BTBGD ^[3].
• Neonatal Differences: In newborns, the pattern may look different. Instead of typical basal ganglia changes, babies may show changes in the thalamus and the perirolandic cortex ^[4][2].
• Reversibility: Remarkably, some of these abnormalities on the MRI can partially or completely improve after your child starts high-dose thiamine and biotin treatment ^[5][3].

The Differential Diagnosis (Look-Alikes)

BTBGD is frequently included in a differential diagnosis alongside other conditions because its “energy crisis” symptoms overlap with inflammatory, toxic, or other mitochondrial problems. Common look-alikes include:

• Leigh Syndrome: This is a severe mitochondrial disorder. Because it also affects the basal ganglia and can cause high lactate (a waste product) in the brain, it is a frequent misdiagnosis ^[2][6]. BTBGD is sometimes called “Leigh-like syndrome” for this reason. A lactate peak on an MRS scan can support an energy-metabolism problem but cannot confirm BTBGD by itself.
• Viral or Autoimmune Encephalitis: Because symptoms often start with a fever and confusion, doctors may initially suspect a brain infection (viral) or the immune system attacking the brain (autoimmune) ^[7][8].
• Acute Necrotizing Encephalopathy (ANE): This rare condition also involves swelling and tissue injury in the brain’s deep structures during a viral illness ^[7].

Solving the Genetic Puzzle

The definitive way to confirm BTBGD is by finding two pathogenic or likely pathogenic variants in the SLC19A3 gene—one from each parent (in trans) ^[9]. However, this isn’t always straightforward.

Standard genetic tests like Whole Exome Sequencing (WES) focus only on the “coding” parts of the gene. Sometimes, a child may have one obvious variant, but the second one is “hidden” in a regulatory region or is a large deletion that standard tests miss ^[10][11]. Also, if a test returns a “Variant of Uncertain Significance” (VUS), it requires specialist interpretation and does not confirm disease on its own.

If your child has only one variant or a negative exome test, but their symptoms and MRI strongly suggest BTBGD, it does not automatically rule the condition out. Your doctor may recommend Whole Genome Sequencing (WGS) or MLPA (a specialized test to find missing chunks of DNA) to find a hidden second variant ^[11][10].

Glossary Note:

• MRS (Magnetic Resonance Spectroscopy): A specialized MRI technique that measures biochemical changes in the brain, such as lactate peaks.
• MLPA: A genetic test designed to detect large missing or duplicated regions of DNA.

Parent’s Diagnostic Checklist

When reviewing your child’s records, look for these key terms:

• Bilateral and Symmetric: This means the changes are on both sides of the brain and look similar—a common feature of metabolic diseases ^[2].
• Restricted Diffusion: Often noted during an acute crisis, this indicates that brain cells are currently under extreme stress ^[12].
• Segregation Testing: This is when parents are tested to see if they each carry one of the mutations found in the child, confirming how the disease was inherited ^[9].